Validation of Coregistered CT-PET Imaging in Determining Tumor Volume and Atelectasis in Patients With Operable Non-Small-Cell Lung Cancer and Tumor Associated Atelectasis
Recruitment status was: Recruiting
CT-PET image fusion has the potential to differentiate 'tumor' from 'atelectasis' much better than the CT-scan in patients with non-small cell lung cancer who also have atelectasis.
This however has never been validated on a histological level. In this study patients with non small cell lung cancer and atelectasis who are eligible for surgery undergo a CT-scan and a PET-scan prior to surgery.
The resection specimen will be compared to the preoperative imaging.
|Study Design:||Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
|Official Title:||The Validation of Coregistered CT-PET Imaging in Determining Tumor Volume and Atelectasis in Patients With Operable Non-Small-Cell Lung Cancer and Tumor Associated Atelectasis With Histological Examination of the Resected Specimen|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00184964
|Contact: Dominic A Schinagl, MDfirstname.lastname@example.org|
|Radboud University Nijmegen Medical Centre||Recruiting|
|Nijmegen, Gelderland, Netherlands, 6500HB|
|Contact: Dominic A Schinagl, MD +31243614515 email@example.com|
|Principal Investigator: Dominic A Schinagl, MD|
|Study Director:||Jan Bussink, MD, PhD||Radiation oncologist, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands|